oral transmucosal fentanyl citrate

This page contains recent news articles, when available, and an overview of oral transmucosal fentanyl citrate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Cephalon Completes Acquisition of Arana Therapeutics  -  ‎Aug 10, 2009‎
TRISENOX((R)) (arsenic trioxide) injection, GABITRIL((R)) (tiagabine hydrochloride), and ACTIQ((R)) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release)

Cephalon Delivers Record Sales in the Second Quarter 2009  -  ‎Aug 4, 2009‎
...hydrochloride extended-release capsules) largely offsetting the continued generic erosion of ACTIQ (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release)

Cephalon Delivers Record Sales in the Second Quarter 2009  -  ‎Aug 7, 2009‎
...hydrochloride extended-release capsules) largely offsetting the continued generic erosion of ACTIQ (oral transmucosal fentanyl citrate) [C-II]. PR-USA.net (press release)

Cephalon Submits NUVIGIL Supplemental New Drug Application for the ...  -  ‎Jun 30, 2009‎
GABITRIL(R) (tiagabine hydrochloride), PROVIGIL(R) (modafinil) Tablets [C-IV], and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release)

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed ...  -  ‎Jun 19, 2009‎
TRISENOX, GABITRIL(R) (tiagabine hydrochloride), PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release)

Cephalon Announces Positive Results from a Phase Three Study of ...  -  ‎Apr 6, 2009‎
TRISENOX(R) (arsenic trioxide) injection, GABITRIL(R) (tiagabine hydrochloride), NUVIGIL and ACTIQ(R) (oral transmucosal fentanyl citrate) (C-II). PR Newswire (press release)

Cephalon Announces Positive Results From a Phase Two Study of ...  -  ‎Mar 17, 2009‎
TRISENOX(R) (arsenic trioxide) injection, GABITRIL(R) (tiagabine hydrochloride), NUVIGIL and ACTIQ(R) (oral transmucosal fentanyl citrate) (C-II). PR Newswire (press release)

Cephalon Launches Takeover Offer for Australian Biotechnology ...  -  ‎Feb 26, 2009‎
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(R) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release)

Cephalon Appoints Sarma P. Duddu as General Manager and Vice ...  -  04 Feb 2009
...in the US that use CIMA drug delivery technology: FENTORA(R) (fentanyl buccal tablet) [C-II] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release),

Cephalon Exercises Option to License Worldwide Rights to ...  -  Feb 2, 2009
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(R) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release),

Cephalon Signs Option Agreement to Acquire Ception Therapeutics  -  Jan 13, 2009
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(R) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release),

Durchbruch bei Durchbruchschmerzen / Abstral®, die erste ...  -  Jan 16, 2009
Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulphate immediate release (MSIR). Pain, 2001. Ad-Hoc-News (Pressemitteilung),

Cephalon Added to S&P 500 Today  -  Nov 14, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. MarketWatch

Cephalon Receives FDA Approval for TREANDA to Treat Patients with ...  -  Oct 31, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. MarketWatch

Cephalon Reports Another Strong Quarter  -  Oct 28, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. MarketWatch

Cephalon Receives FDA Approval for TREANDA to Treat Patients with ...  -  Nov 3, 2008
GABITRIL ® (tiagabine hydrochloride), NUVIGIL ™ (armodafinil) Tablets [C-IV] and ACTIQ ® (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release),

Cephalon and Eurand Announce Notification of Generic Filing for ...  -  21 Oct 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets (C-IV) and ACTIQ(R) (oral transmucosal fentanyl citrate) (C-II). SYS-CON Media,

Other News To Note  -  Sep 29, 2008
...related to marketing practices associated with Actiq (oral transmucosal fentanyl citrate), Provigil (modafinil), and GabitRil (tiagabine hydrochloride). TMCnet

Cephalon Concludes All Outstanding Federal and State Government ...  -  Sep 29, 2008
States -- Actiq(R) (oral transmucosal fentanyl citrate) [C-II], Provigil(R) (modafinil) Tablets [C-IV], and GabitRil(R) (tiagabine hydrochloride). MarketWatch

Cephalon Launches National Consumer Awareness Initiative on ...  -  Oct 14, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire (press release),

Cephalon Receives Complete Response Letter Regarding Request For ...  -  16 Sep 2008
GABITRIL® (tiagabine hydrochloride), NUVIGIL™ (armodafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. Medical News Today (press release),

Drug theft's a big concern  -  Aug 26, 2008
NILES - A theft of Oral Transmucosal Fentanyl Citrate (OTFC) from a home in 1100 block of Cass Street on Thursday, Aug. 21, around 8 pm has become a big Niles Daily Star,

'Lollipop' drug stolen from Niles home  -  Aug 22, 2008
The drug that was taken - oral transmucosal fentanyl citrate (OTFC) - is an effective long-term treatment for cancer. It is packaged in a form commonly WOOD-TV,

Dangerous drug stolen.  -  Aug 23, 2008
Its scientific name is Oral Transmucosal Fentanyl Citrate, its brand name is Actiq… and its street name is “Lollypop� or “Percopop�, because it’sa lozenge WKZO News,

Cephalon Exceeds Both Sales and Earnings Guidance for Second ...  -  Jul 29, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. Earthtimes (press release),

Journal of Clinical Oncology Publishes Study of Cephalon ...  -  Jul 15, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. StreetInsider.com (subscription),

Gli effetti del fentanil  -  Jul 25, 2008
The safety and efficacy of oral transmucosal fentanyl citrate for preoperative sedation in young children. Anesth. Analg. 1996; 86(3): 1200-1205. ECPlanet,

Cephalon Announces Issuance of Patent for AMRIX  -  Jun 17, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. Earthtimes (press release),

Cephalon Announces FDA Advisory Committee Recommendation Against ...  -  May 6, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. Earthtimes (press release),

Cephalon Announces European Commission Approval of EFFENTORA for ...  -  Apr 14, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PR Newswire UK (press release),

Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon ...  -  Mar 31, 2008
GABITRIL® (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. Business Wire (press release),

BioDelivery Sciences To Present BEMA(TM) Fentanyl Data At The 24th ...  -  Feb 13, 2008
Actiq®, also known as oral transmucosal fentanyl citrate, is a solid formulation of fentanyl citrate on a handle that is designed to be slowly dissolved in Medical News Today (press release),

inVentiv Selling Solutions Selected to Provide Sales Team for ...  -  Mar 6, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. SunHerald.com,

Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance  -  Feb 13, 2008
...of $512.6 million, a decrease of only 22 percent despite a full year of generic competition to ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. PharmaLive.com (press release),

Cephalon's EFFENTORA Receives Positive Opinion from European ...  -  Jan 24, 2008
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. CNNMoney.com

Cephalon Submits Supplemental New Drug Application for FENTORA  -  Nov 12, 2007
...oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq(R)), to FENTORA, do not substitute FENTORA on a mcg per mcg basis. CNNMoney.com

Cephalon Settles Drug Marketing Investigation for $425 Million  -  Nov 14, 2007
...asked Cephalon for promotional and research information for its narcotic painkillers Actiq (oral transmucosal fentanyl citrate) and Fentora (fentanyl FDA news (subscription),

Cephalon Announces Strong Third Quarter Financial Results  -  Nov 8, 2007
...(tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. CNNMoney.com

Cephalon Appoints Valli F. Baldassano as Executive Vice President ...  -  Nov 1, 2007
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. CNNMoney.com

ã€?页é?¢è°ƒè‰²ç‰ˆ  -  Oct 23, 2007
...(oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its US products is 金�界,

FDA Reiterating Concerns With Fentora  -  Oct 3, 2007
...is a unique, potent opioid medication and should not be substituted for Cephalon’s cancer pain treatment Actiq (oral transmucosal fentanyl citrate), FDA news (subscription),

Cephalon Submits New Drug Application for TREANDA for the ...  -  Sep 21, 2007
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. CNNMoney.com

Cephalon Announces Completion of Anticipated PROVIGIL Label Updates  -  Sep 17, 2007
...(tiagabine hydrochloride), NUVIGIL and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. CNNMoney.com

Warning Issued On Off-Label Use of Fentora  -  Sep 17, 2007
FENTORA is not bioequivalent to or a generic version of ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; therefore, FENTORA should not be substituted ClinicalMind,

Cephalon Announces Positive Results from a Pivotal Study of ...  -  Aug 16, 2007
...oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq(R)), to FENTORA, do not substitute FENTORA on a mcg per mcg basis. CNNMoney.com

FDA Grants Orphan Drug Designation to TREANDA, an Investigational ...  -  Aug 29, 2007
GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. CNNMoney.com

Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily ...  -  Aug 23, 2007
GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and NUVIGIL(TM) (armodafinil) Tablets [C-IV]. CNNMoney.com

[an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] :
 
Web health.mongabay.com/health


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com


COPYRIGHT 2007 MONGABAY.COM